Navigation Links
Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
Date:11/2/2012

PRINCETON, N.J., Nov. 2, 2012 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced an invitation to attend the presentation of data from its Phase 3 clinical studies.  The presentation will be held on November 5, 2012 at 7:30 a.m. pst in the Bernards Room at the Millennium Biltmore Hotel, 506 South Grand Avenue, Los Angeles. Participants are also invited to attend the presentation via a live webcast available through the "What's New" section at www.Omthera.com.  The webcast will be available for replay following the presentation.

The Phase 3 EVOLVE (EpanoVa fOr Lowering Very High triglyceridEs) trial was a 12 week, multi-center, randomized, double-blind, study of 399 patients, evaluating the efficacy and safety of three doses of Epanova in patients with fasting triglyceride levels of at least 500 mg/dL but less than 2000 mg/dL.  Patients were randomized into four dosing groups: Epanova 2g/day; Epanova 3g/day; Epanova 4g/day; and control (olive oil 4 g/day).  The primary endpoint of the trial was the percentage change in triglyceride level from baseline to week 12 and the secondary endpoint was the reduction in Non-HDL-C.

The Phase 3 ESPRIT (Epanova combined with a Statin in Patients with HypertRiglycerIdemia to Reduce Non-HDL CholesTerol) trial was a six-week, randomized, double-blind, parallel group study of 647 patients to assess the efficacy and safety of add-on Epanova to statin therapy in patients with persistent hypertriglyceridemia and high risk for cardiovascular disease. Patients were randomized into three dosing groups; Epanova 2g/day; Epanova 4g/day; and control (olive oil 4 g/day).  The primary objective of the study was to evaluate the efficacy of adding Epanova (2g or 4g daily) to statin monotherapy for lowering Non-HDL-C. Secondary objectives are to evaluate the safety of the Epanova and statin combination thera
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 32,890 boxes of ...
(Date:8/20/2014)... YORK , Aug. 20, 2014 ... new market research report is available ... Market for Hospital-Acquired Infection Control (Sterilization, ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html ... healthcare-associated infections (HAIs), demand has increased ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
(Date:8/21/2014)... by T-type calcium channels in the thalamic reticular ... calcium. These channels enable thalamic reticular nucleus neurons ... enter a hyper-excited state. , In order to ... seizures, the researchers conducted an experiment to induce ... to delete the T-type calcium channel CaV3.3. The ...
(Date:8/21/2014)... August 21, 2014 ... Peripheral Vascular Devices Market by Angioplasty ... Catheter (IVUS, OCT), IVC Filter (Retrievable), ... 2018" analyzes and studies the major ... the U.S. and Canada. , Browse ...
(Date:8/21/2014)... 21, 2014 mynt welcomes industry leaders ... to join its growing company. Since its pre-launch in ... product sales and continues to gain momentum leading up ... Rob and Tiffanie came into network marketing by chance. ... number of network marketing companies. Tiffanie needed help at ...
(Date:8/21/2014)... 21, 2014 One of the emerging trends ... ostomy drainage bags. This increases the availability and accessibility of ... forecast the Global Ostomy Care Accessories market to ... 2013-2018. According to the report, the Global Ostomy Care Accessories ... is one of the major drivers. The number of procedures ...
(Date:8/21/2014)... Raleigh, NC (PRWEB) August 21, 2014 ... proteins produced by Staph bacteria has been used to ... just posted an article on the new research. ... at the University of Western Australia treated mesothelioma ... that it killed the cancer cells while simultaneously stimulating ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Study Finds Bacteria Compound Shrinks Mesothelioma Tumors, According to Surviving Mesothelioma 2
... , , DALLAS ... PHNS Inc. announced its,new "24/7 Claims Acceleration" services for U.S. ... and China -based IT and business,process outsourcing provider iSoftStone. ... in Tianjin, China . All of this,new team have ...
... Ariz. , Feb. 9 Cancer Clinics of ... oncologists has announced the addition of The West Clinic, ... http://www.newscom.com/cgi-bin/prnh/20080612/AQTH094LOGO ) , "CCE is very pleased to welcome The ... Pennsylvania Oncology, Philadelphia, PA and Chairman of CCE. ...
... , KNOXVILLE, Tenn. , Feb. 9 Team ... the largest suppliers of outsourced healthcare professional staffing and administrative services ... , today announced results for its fourth quarter and full fiscal ... be a landmark quarter for TeamHealth, and we are pleased to ...
... , BOCA RATON, Fla. , Feb. 9 ... and Prevention, nearly one in four women in the United ... or boyfriend at some point in her life. Another startling statistic ... in 5 Canadian teens experience dating violence. , (Photo:   http://www.newscom.com/cgi-bin/prnh/20100209/LA52551 ...
... , Feb. 9 International Planned Parenthood ... and Young People in the 21st Century," advocates policies ... of parents and the moral values of our society, ...  ) , The report promotes contraceptive sex education ...
... STATESVILLE, N.C. , Feb. 9 Jimmy Johnson ... excellence! No, not the four-time Sprint Cup champion Jimmie Johnson, ... host. , The newly named ExtenZe spokesman and star of the ... Speedway on Sunday, Feb. 14 , the day of the Daytona ...
Cached Medicine News:Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 2Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 3Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 4Health News:The West Clinic Joins Cancer Clinics of Excellence (CCE) 2Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 2Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 3Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 4Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 5Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 6Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 7Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 8Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 9Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 10Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 11Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 12Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 13Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 14Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 15Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 16Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 17Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 18Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 19Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 20Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 21Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 22Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 23Health News:ADT Safety Tips: Personal Safety 2Health News:ADT Safety Tips: Personal Safety 3Health News:ADT Safety Tips: Personal Safety 4Health News:Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority 2Health News:Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona 2Health News:Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona 3
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... Plastic and fabric specialty drapes ... gynecology. Steri-Drape absorbent prevention fabric ... fluid strike-through reducing the need ... Drape Pack, Op tape, Hand ...
... top design takes into account a wide ... flexible working environment for the surgical team. ... be matched exactly to your patients height. ... creates superior access for image amplification procedures. ...
... Mitek is the Market leader in soft ... Suture, DePuy Mitek has developed the latest ... open shoulder repair. ORTHOCORD Suture is as ... the market. Most importantly, ORTHOCORD Suture handles ...
Medicine Products: